Logo image of DBAN.DE

DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis

FRA:DBAN - Deutsche Boerse Ag - DE000A1TNUT7 - Common Stock - Currency: EUR

25.2  -0.05 (-0.2%)

Fundamental Rating

5

Overall DBAN gets a fundamental rating of 5 out of 10. We evaluated DBAN against 109 industry peers in the Capital Markets industry. DBAN has an excellent financial health rating, but there are some minor concerns on its profitability. DBAN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year DBAN was profitable.
DBAN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DBAN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DBAN reported negative operating cash flow in multiple years.
DBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFDBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

DBAN has a Return On Assets of 6.29%. This is amongst the best in the industry. DBAN outperforms 81.65% of its industry peers.
With a Return On Equity value of 8.26%, DBAN perfoms like the industry average, outperforming 55.05% of the companies in the same industry.
DBAN has a better Return On Invested Capital (4.84%) than 70.64% of its industry peers.
Industry RankSector Rank
ROA 6.29%
ROE 8.26%
ROIC 4.84%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
DBAN.DE Yearly ROA, ROE, ROICDBAN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Profit Margin, with a value of 43.12%, DBAN belongs to the top of the industry, outperforming 87.16% of the companies in the same industry.
In the last couple of years the Profit Margin of DBAN has declined.
DBAN has a better Operating Margin (45.95%) than 83.49% of its industry peers.
In the last couple of years the Operating Margin of DBAN has declined.
With an excellent Gross Margin value of 93.60%, DBAN belongs to the best of the industry, outperforming 88.99% of the companies in the same industry.
In the last couple of years the Gross Margin of DBAN has remained more or less at the same level.
Industry RankSector Rank
OM 45.95%
PM (TTM) 43.12%
GM 93.6%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
DBAN.DE Yearly Profit, Operating, Gross MarginsDBAN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for DBAN has been reduced compared to 1 year ago.
DBAN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DBAN has a worse debt to assets ratio.
DBAN.DE Yearly Shares OutstandingDBAN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DBAN.DE Yearly Total Debt VS Total AssetsDBAN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.92 indicates that DBAN is not a great score, but indicates only limited risk for bankruptcy at the moment.
DBAN has a better Altman-Z score (2.92) than 74.31% of its industry peers.
DBAN has a debt to FCF ratio of 4.14. This is a neutral value as DBAN would need 4.14 years to pay back of all of its debts.
The Debt to FCF ratio of DBAN (4.14) is better than 78.90% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that DBAN is not too dependend on debt financing.
DBAN's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. DBAN outperforms 70.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 4.14
Altman-Z 2.92
ROIC/WACCN/A
WACCN/A
DBAN.DE Yearly LT Debt VS Equity VS FCFDBAN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 6.68 indicates that DBAN has no problem at all paying its short term obligations.
DBAN has a Current ratio of 6.68. This is amongst the best in the industry. DBAN outperforms 92.66% of its industry peers.
DBAN has a Quick Ratio of 6.68. This indicates that DBAN is financially healthy and has no problem in meeting its short term obligations.
DBAN has a Quick ratio of 6.68. This is amongst the best in the industry. DBAN outperforms 92.66% of its industry peers.
Industry RankSector Rank
Current Ratio 6.68
Quick Ratio 6.68
DBAN.DE Yearly Current Assets VS Current LiabilitesDBAN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.70% over the past year.
Measured over the past years, DBAN shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.13% on average per year.
Looking at the last year, DBAN shows a very strong growth in Revenue. The Revenue has grown by 22.52%.
The Revenue has been growing slightly by 7.25% on average over the past years.
EPS 1Y (TTM)0.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-70.3%
Revenue 1Y (TTM)22.52%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-44.94%

3.2 Future

DBAN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.48% yearly.
DBAN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.23% yearly.
EPS Next Y-39.86%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
EPS Next 5YN/A
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3Y-0.23%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DBAN.DE Yearly Revenue VS EstimatesDBAN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50M -50M 100M 150M 200M
DBAN.DE Yearly EPS VS EstimatesDBAN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

DBAN is valuated reasonably with a Price/Earnings ratio of 9.73.
DBAN's Price/Earnings ratio is rather cheap when compared to the industry. DBAN is cheaper than 81.65% of the companies in the same industry.
DBAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.46.
The Price/Forward Earnings ratio is 7.48, which indicates a rather cheap valuation of DBAN.
Based on the Price/Forward Earnings ratio, DBAN is valued cheaper than 97.25% of the companies in the same industry.
DBAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.73
Fwd PE 7.48
DBAN.DE Price Earnings VS Forward Price EarningsDBAN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

82.57% of the companies in the same industry are more expensive than DBAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.83
EV/EBITDA N/A
DBAN.DE Per share dataDBAN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

DBAN's earnings are expected to decrease with -14.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%

More info and screens

4

5. Dividend

5.1 Amount

DBAN has a Yearly Dividend Yield of 3.98%.
DBAN's Dividend Yield is a higher than the industry average which is at 5.91.
DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.98%

5.2 History

The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
DBAN.DE Yearly Dividends per shareDBAN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
DBAN.DE Yearly Income VS Free CF VS DividendDBAN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

More info and screens

DEUTSCHE BETEILIGUNGS AG

FRA:DBAN (7/21/2025, 7:00:00 PM)

25.2

-0.05 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-07 2025-08-07
Inst Owners13.1%
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap473.76M
Analysts89.23
Price Target41.06 (62.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.98%
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP0%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.73
Fwd PE 7.48
P/S 3.79
P/FCF 14.83
P/OCF 14.46
P/B 0.73
P/tB 0.79
EV/EBITDA N/A
EPS(TTM)2.59
EY10.28%
EPS(NY)3.37
Fwd EY13.37%
FCF(TTM)1.7
FCFY6.74%
OCF(TTM)1.74
OCFY6.92%
SpS6.65
BVpS34.75
TBVpS32.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 8.26%
ROCE 6.87%
ROIC 4.84%
ROICexc 5.19%
ROICexgc 5.54%
OM 45.95%
PM (TTM) 43.12%
GM 93.6%
FCFM 25.55%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-35.11%
ROICexcg growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 4.14
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.65%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 59.24%
Current Ratio 6.68
Quick Ratio 6.68
Altman-Z 2.92
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-70.3%
EPS Next Y-39.86%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
EPS Next 5YN/A
Revenue 1Y (TTM)22.52%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-44.94%
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3Y-0.23%
Revenue Next 5YN/A
EBIT growth 1Y14.61%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-23.9%
EBIT Next 3Y0.97%
EBIT Next 5YN/A
FCF growth 1Y242.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y251.24%
OCF growth 3YN/A
OCF growth 5YN/A